Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma

The lack of information concerning individual variation in drug-metabolizing enzymes is one of the most important obstacles for designing personalized medicine approaches for hepatocellular carcinoma (HCC) patients. To assess cytochrome P450 (CYP) in the metabolism of endogenous and exogenous molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Wen, Qiang, Li, Sai-Fei, Zhang, Yun-Fei, Gao, Na, Tian, Xin, Fang, Yan, Gao, Jie, Cui, Ming-Zhu, He, Xiao-Pei, Jia, Lin-Jing, Jin, Han, Qiao, Hai-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226607/
https://www.ncbi.nlm.nih.gov/pubmed/27203676
http://dx.doi.org/10.18632/oncotarget.9437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226607/
https://www.ncbi.nlm.nih.gov/pubmed/27203676
http://dx.doi.org/10.18632/oncotarget.9437

Ejemplares similares